Background: To study cathepsin K location in oral tongue squamous cell carcinoma
INTRODUCTION
Oral cancer is the tenth most common cancer in men worldwide with over 40 000 new cases are expected to be diagnosed every year, in which over 50% of these cases are tongue cancers. Despite the advances in tongue cancer therapy including surgery, chemotherapy, and radiotherapy, the 5 years survival has not improve significantly with an average of 50% survival rate (1, 2) .
Cathepsin K, a powerful collagenase, is one of the major players in the process of extracellular matrix turnover (3) . Cathepsin K activity is also important for non-skeletal metabolism, both in normal and pathological conditions (4, 5, 6, 7) . For instance, although in normal skin cathepsin K is mainly absent, it is found in dermal fibroblasts in recent surgical scars (3), being essential for the dynamic equilibrium between live mesenchymal cells and matrix synthesis and degradation (8) .
Cathepsin K has also been studied in cancer as a major player in the ever-changing tumor microenvironment (TME), participating in the imbalance of extracellular matrix degradation, especially at the tumor invasive front. In skin squamous cell carcinoma (SSSC), cathepsin K in the stromal tissue facilitates cancer invasion (4, 5) . Cathepsin K expression in fibroblasts was up-regulated through interleukin 1-alpha (IL-1α), which is secreted from SSCC cells in indirect co-culture experiments, showing that the cross talk between cancer and stromal cells are of paramount importance in understanding the complex process of tumor progression (5) . In previous work, we reported the presence of cathepsin K in oral tongue squamous cell carcinomas (OTSCCs), with an association between expression pattern and prognosis (9) . Down-regulation of cathespsin K significantly impaired OTSCC cell invasion in vitro 3D myoma model (9) . However, the role of cathepsin K in the progress of oral carcinomas is still relatively unknown (10) .
Since IL-1α was shown to up-regulate cathepsin K expression in SSCCs, this study aimed to investigate the role of IL-1α in OTSCCs, regarding mainly the regulation of cathepsin K expression, and its effects on cancer invasiveness. The location of cathepsin K was also studied within OTSCC tissue and cultured cancer cells.
MATERIALS AND METHODS

Ethics Statement
All patients signed an informed consent form and data inquiry was approved by the 
Patient Samples and Immunohistochemistry
The 10 samples used in this study were selected to be most representative of the membranous expression pattern of cathepsin K, out of a previously described group of 121 OTSCC samples (9) . Archival specimens of OTSCC samples, surgically treated at the Oulu University Hospital in 1981-2009, were retrieved from the Department of Pathology, Oulu University Hospital. Slides were immunostained for cathepsin K with the mouse anti-human cathepsin K IgG2b antibody (Biovendor, Candler, NC, USA) at a 1:500 dilution as described previously (9) . For validation, we have used positive controls (human bone tissue) and negative controls (by omitting the primary antibody or using mouse primary antibody isotype control. 
Cell lines
Results
The myoma organotypic experiment was done as described previously (14), with few modifications. In preparation for the experiments, 9 myoma disks were incubated overnight in full DMEM-F12 1:1 culture medium and other 9 myoma disks were incubated in the same medium with the addition of 5ng/ml human recombinant IL-1α (Sigma-Aldrich 4 . All experiments were performed in triplicate. Cells were allowed to attach overnight and moved to uncoated nylon disks on curved steel grids in 12-well plates.
One ml of medium with or without IL-1α was added to each seeded myoma disk. During the experiment, fresh media was added every third day, until the tenth day. Then the disks were at the borders of the myoma, as described previously (14, 15) .
IL-1α experiment
Cells were cultured until 80% confluence, 1x106 cells were plated for each experiment.
Cells were allowed to attach for 24 hours and starved of serum or cell growth supplements for additional 24 hours. After that, cells were treated with 5ng/ml recombinant human IL-1α in opti-MEM medium (R&D Systems, Minneapolis, MN, USA) for additional 24 hours.
Total RNA extraction
Cells were washed once with chilled PBS and 1.5 ml of the commercial mixture of guanidine thiocyanate and phenol, TRI reagent® (Sigma-Aldrich) was added. RNA extraction was performed according to manufacturer's instructions. Samples were resuspended in RNase free water up to 30 µl. Total RNA quantitation and purity were determined through spectrophotometry in NanoDrop instrument (Thermo Scientific).
Reverse transcriptase polymerase chain reaction (RT-PCR)
Complementary DNA (cDNA) was synthesized using 1 µg of total RNA per sample.
The reaction was performed using 200 U of the reverse transcriptase RevertAidTM (Fermentas-Thermo Scientific, Fremont, CA, USA), 20 U of the RNase inhibitor RiboLockTM, 1mM of dNTP mix (Fermentas-Thermo Scientific) and 100 pmol of random hexamers (Fermentas-Thermo Scientific). Due to the use of random hexamers, the reaction was designed to include an incubation period of 10 minutes at 25 ºC followed by 60 min at 42 ºC for cDNA synthesis and 10 minutes at 70 ºC for enzyme inactivation.
Polymerase chain reaction (PCR)
The PCR reactions were performed with primer sequences specific for the amplification of the following genes: cathepsin K primers (forward 5'-ccgcagtaatgacacccttt-3' and reverse 5'-gcacccacagagctaaaagc-3'), IL-1α (forward 5'-aatgacgccctcaatcaaag-3' and reverse 5'-tgggtatctcaggcatctcc-3'), TGF-β1 (forward 5'-gtggaaacccacaacgaaat-3' and 5'-reverse cacgtgctgctccactttta-3') and beta-actin (forward 5'-aactgggacgacatggagaaaa-3' and reverse 5´-ag aggcgtacagggatagcaca-3') which was used as a reference gene. Briefly, PCR reactions were done in 45 cycles of 5 minutes at 95 ºC, 2 minutes at 94 ºC, 1 minute at 54 ºC, 30 seconds at 72 ºC and a final extension at 72 ºC for 10 minutes, using the DNA polymerase AmpliTaqGold™ (Fermentas). The PCR products were then separated by electrophoresis in a 1% agarose gel.
Total protein extracts
Cells were scraped from cell culture plates with the addition of ice cold lysis buffer (50 mM Tris, 10 mM CaCl2, 150 mM NaCl, 0.05% Brij, pH 7.5). The collected cells in the lysis buffer were kept under rotating agitation overnight at 4 °C. Following this incubation, the supernatant was separated from the insoluble precipitate by centrifugation at 12000 x g for 10 min at 4 °C. Protein extracts were then kept in -70 °C until use. Protein concentrations were measured through the Lowry colorimetric assay, Bio-Rad DC protein assay (Bio-Rad, Hercules, CA, USA).
Exosome isolation
HSC-3 cells were washed with PBS, and cultured in Opti-MEM® I Reduced Serum Medium (Life Technologies) with the addition of 50 μ M 4-aminophenylmercuric acetate (APMA; Sigma-Aldrich), as described previously (16) . Incubation lasted for 6 h, after which the media were collected and the exosomes were isolated with ExoQuick-TC™ kit (Systems Biosciences, CA, USA) according to the manufacturer's instructions. Briefly, the ExoQuick-TC solution was added to the supernatant in a 5:1 ratio. This sample/ExoQuick solution was incubated at 4°C overnight. The solution was then centrifuged 1500 × g for 30 min and the supernatant was removed. The precipitate was suspended in 1 × RIPA-buffer (25mM TrisHCl pH 7.6, 150mM NaCl, 1% NP-40, 1% sodium deoxycholate, and 0.1% SDS) for 5 minutes in room temperature for Western blotting.
Western blot
Western blot analysis using a murine monoclonal cathepsin K antibody in a 1:1000 dilution (Biovendor) was performed as described previously (15) . As a positive control for cathepsin K western blot, total protein extract from THP-1 cells was used.
Enzyme-linked quantitative immunoassay (ELISA) for cathepsin K
Cell homogenates and media samples were measured for their cathepsin K content using the ELISA kit composed of polyclonal sheep anti cathepsin K antibody coated microtiterstrips (Biomedica Gruppe, Vienna, Austria). Fifty µl of undiluted sample was added to each well. Standard curves were calculated according to manufacturer's instructions.
Cathepsin K final quantitation was calculated as a ratio relative to total protein content from each sample.
Statistical analysis
Kruskall-Wallis test was used to check the statistical significance of grouped data.
Values of P < 0.01 were considered as statistically significant.
RESULTS
Cathepsin K is not located solely in acidic lysosomal subcellular compartments in OTSCC cells
In vivo, some OTSCC cells presented a pattern of cathepsin K accumulation in cytoplasm, whereas in other cases it was accumulated in proximity of the cytoplasmic membrane. We hypothesized that, although we could not see positive immunohistochemistry staining for cathepsin K in the extracellular matrix, it still might be secreted from OTSCC cells into the TME within exosomes (9; Figure 1A ). Therefore, we performed an experiment where we used PMA, a known tumor promoter, to induce cell stress and lysosome purging. In our experiments, at the initial time point, HSC-3 cells showed that the majority of cathepsin K (stained green) co-localized with lysosomes (labeled red; Figure 1B ). In other time points of PMA treatment, there was a noticeable scattering of cathepsin K throughout the cytoplasm.
The same is not true for the lysosomes, which also migrated, although to different directions, as clearly demonstrated (last three panels of Figure 1B ). These results demonstrate that cathepsin K vesicles are carried towards the cellular membrane, similarly to what is shown in the in vivo samples ( Figure 1A) . However, by these methods we could not identify cathepsin K in the extracellular spaces. Instead, in a complementary investigation, we found that in cultured HSC-3 cells, small amounts of cathepsin K were actualy found in exosomes secreted into culture media (Figure 2A ).
Cathepsin K basal mRNA levels are variable between all cell lines
The mRNA levels for cathepsin K in all of the cell lines did not differ significantly neither when compared individually nor when analyzed in groups of epithelial or mesenchymal origin. However, these results demonstrated that, at basal levels, cathepsin K mRNA levels were slightly higher in HSC-3, CAFs and GFs, than in HMK and IHMK ( Figure 2C ).
Cathepsin K increased expression is mediated by IL-1α
The original hypothesis of this investigation proposed that IL-1α would mediate cathepsin K regulation in the cross-talk between oral epithelial and mesenchymal cell lines, like in the case of SSCC (17) . First, we assessed IL-1α mRNA for each cell line. Our results
showed that mesenchymal cells (CAFs and GFs) expressed low levels of IL-1α mRNA. Oral epithelial cell lines (HMK and IHMK) and the OTSCC cell line HSC-3 expressed more IL-1α mRNA ( Figure 2B) . We, then, cultivated all cells with media supplemented with IL-1α for 24
hours, and found out that, in all cell lines, there was a slight increase, in cathepsin K mRNA levels ( Figure 2D ).
Cathepsin K protein expression levels are elevated by exogenous IL-1α
After supplementing culture media with IL-1α, we also assessed cathepsin K protein levels with ELISA, from cell lysates and culture media samples. Initial cathepsin K levels in cell lysates were quite low ( Figure 2E ) and the highest level was found in the CAFs. After IL-1α treatment, there was a noticeable increase in the amount of cathepsin K levels. The highest average cathepsin K level was observed in the fibroblast cell lines (CAFs and GFs)
demonstrating their capacity to quickly respond to IL-1α. The epithelial cell lines were also responsive to IL-1α treatment, albeit to a lesser degree. (Figure 2E ).
Exogenous IL-1α does not promote secretion of cathepsin K
As we found that small amounts of cathepsin K in exosomes secreted by HSC-3 cells into media (Figure 2A ), we assessed if IL-1α-driven cathepsin K overexpression could also increase extracellular cathepsin K. We measured cathepsin K levels in all of our cell lines, most of the cathepsin K remained intracellular, and in case of HSC-3, CAFs and GFs there was even a reduction in the amount of secreted cathepsin K to almost non-detectable levels after IL-1α treatment ( Figure 2E ).
IL-1α has no effect on the invasiveness of HSC-3 cells in the myoma organotypic model
So far, it was established that cathepsin K levels, particularly in CAFs and GFs, could be affected by the presence of IL-1α. Therefore, we aimed to assess whether IL-1α-driven cathepsin K levels could affect HSC-3 invasiveness in the myoma organotypic invasion model. We designed six different experimental conditions, both including and excluding IL-1α supplementation and co-culture of OTSCC cells with GFs or CAFs. Our results confirm the HSC-3 cells intrinsic invasiveness, although there was no significant change in the invasion depth as a result of IL-1α treatment, or co-cultures with neither GFs nor CAFs (Figure 3 ).
DISCUSSION
The role of cathepsin K outside of bone extracellular remodeling is still relatively unknown. In spite of being virtually absent from normal tissue and present in both cancer cells and tumor stroma, this differential expression has, so far, shed only a little light on its function in the TME. With its powerful collagenase activity, it is possible to argue for an intense role of cathepsin K in TME matrix turnover, similar to wound healing and inflammatory processes (17, 18) . However, cathepsin K presence in carcinoma cells points to a more complex dynamic, where the cross-talk between cancer and TME cells is of paramount importance to the regulation of its expression. Our efforts aimed to provide some insight into the relevance of IL-1α in the OTSCC microenvironment.
In our in vivo findings, we have extensively described the concentration of cathepsin K close to the cellular membrane (9) . This membranous expression pattern, although not relevant for prognosis, suggested that OTSCC cells might have the ability to secrete cathepsin K-containing vesicles. Secretion of cathepsin K into the extracellular environment outside the bone tissue has already been reported in thyroid tissue (19, 20) . Although the membranous localization is suggestive of cathepsin K secretion and the presence of cathepsin K in purified exosomes from HSC-3 cells, the immunostaining results did not show extracellular cathepsin K in the TME. In our in vitro experiments, neither inducing lysosomal purging nor stimulating cathepsin K synthesis has resulted in significant extracellular cathepsin K production. In PMA treated cells, cathepsin K containing vesicles seemed to scatter towards Tumor cell invasion is an extremely important OTSCC hallmark, being essential for tumor progression. The invasion process involves an intricate collection of cellular processes, which will result in cancer cell detachment from the primary tumor, remodeling of the extracellular matrix and invasion of neighboring tissues and structures (21) . As a powerful collagenase, cathepsin K's putative role in OTSCCs is to aid both carcinoma and associated host cells in the invasion process, with both cancer cells themselves and stromal cells showing overexpression and significant remodeling of the TME (6, 22, (24) (25) .
Although, in our in vivo samples, there was evident overexpression of cathepsin K in both the OTSCC cells and the TME, with significance for prognosis, in our current investigation, in vitro, we found no differences in the invasion ability of HSC-3 cells neither as a result of IL-1α-derived cathepsin K overexpression nor after co-culture with oral fibroblasts.
We interpret the lack of increased invasion by HSC-3 cells, due to the fact that they are already exceedingly invasive when cultured in the myoma organotypic model, the results suggest that the increase in cathepsin K by IL-1α in both OTSCC and fibroblast cell lines is of little consequence to this process. We also postulate that cathepsin K activity is being modulated indirectly by other signaling pathways and by the degradation of myoma tissue: a highly complex, hypoxic and enriched environment (23) That assumption is supported by our previous findings, where it was shown that HSC-3 cells knocked-down for cathepsin K had a significant decrease in invasive potential, when compared to controls (9) , demonstrating that cathepsin K was important for invasion.
In conclusion, our results show that IL-1α induces cathepsin K in epithelial and mesenchymal cell lines in vitro. Our findings also suggest that, in OTSCC cells, subcellular compartments, although not secreted, can quickly mobilize cathepsin K. The role for cathepsin K intracellular movement is still unknown; however, we can assume that it may be an important action by the cancer cells to aid in their survival and invasion throughout the tumor progression. 
